Fast and Controlled Release of Triamcinolone Acetonide from Extrusion-Spheronization Pellets Based on Mixtures of Native Starch with Dextrin or Waxy Maize Starch

REFERENCES

• Almeida-Prieto S., Blanco-Méndez J., Otero-Espinar F. J. Image analysis of the shape of granulated powder grains. J. Pharm. Sci. 2004; 93: 621–634
   PubMed Web of Science ®Google Scholar
• Almeida-Prieto S., Blanco-Méndez J., Otero-Espinar F. J. Starch-dextrin mixtures as base excipients for extrusion-spheronization pellets. Eur. J. Pharm. Biopharm. 2005; 59: 511–521
   PubMed Web of Science ®Google Scholar
• Awad G. A. S., Charrueau C. A. A., Allain P., Chaumeil J. C. Formulation and evaluation of bioadhesive pellets containing different carbomers made by extrusion-spheronization. STP Pharma. Sci. 2002; 12: 157–162
   Google Scholar
• Baert L., Remon J. P. Influence of amount of granulation liquid on the drug release rate from pellets made by extrusion spheronization. Int. J. Pharm. 1993; 95: 135–141
   Web of Science ®Google Scholar
• Bianchini R., Bruni G., Gazzaniga A., Vecchio C. Influence of extrusion-spheronization on the physical properties of d-indobufen pellets containing pH adjusters. Drug Dev. Ind. Pharm. 1992; 21: 1485–1501
   Google Scholar
• Chatchawalasasin J., Podczeck F., Newton J. M. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation. Int. J. Pharm. 2004; 275: 41–60
   PubMedGoogle Scholar
• Chopra R., Alderborn G., Podczeck F., Newton J. M. The influence of pellet shape and surface properties on the drug release from uncoated and coated pellets. Int. J. Pharm. 2002; 239: 171–178
   PubMed Web of Science ®Google Scholar
• Conine J. W., Hadley H. R. Preparation of pharmaceutical spheres. Drug and Cosmet. Ind. 1970; 90: 38–41
   Google Scholar
• Costa F. O., Pais A. A. C. C., Sousa J. J. S. Analysis of formulation effects in the dissolution of ibuprofen pellets. Int. J. Pharm. 2004; 270: 9–19
   PubMedGoogle Scholar
• Erkoboni D. F. Extrusion-spheronization as a granulation technique. Handbook of pharmaceutical granulation technology, D. M. Parikh. CRC. Press, New York 1997; 333–368
   Google Scholar
• Follonier N., Doelker E. Biopharmaceutical comparison of oral multi-unit and single-unit sustained-release dosage form. STP Pharma. Sci. 1992; 2: 141–158
   Google Scholar
• Ghali E. S., Klinger G. H., Schwartz J. B. Modified drug release from beads prepared with combinations of two grades of microcrystalline cellulose. Drug Dev. Ind. Pharm. 1989a; 15: 1455–1473
   Web of Science ®Google Scholar
• Ghali E. S., Klinger G. H., Schwartz J. B. Thermal treatment of beads with wax for controlled release. Drug Dev. Ind. Pharm. 1989b; 15: 1311–1328
   Web of Science ®Google Scholar
• Goskonda S. R., Hileman G. A., Upadrashta S. M. Controlled release pellets by extrusion-spheronization. Int. J. Pharm. 1994; 111: 89–97
   Web of Science ®Google Scholar
• Krogars K., Heinämäki J., Vesalahi J., Marvola M., Antikainen O., Yliruusi J. Extrusion-spheronization of pH-sensitive polymeric matrix pellets for possible colonic drug delivery. Int. J. Pharm. 2000; 199: 187–194
   PubMed Web of Science ®Google Scholar
• Milojevic S., Newton J. M., Cummings J. H., Gibson G. R., Botham R. L., Ring S. G., Stockham M., Allwood M. C. Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using glucose pellets. J. Control. Release. 1996; 38: 85–94
   Web of Science ®Google Scholar
• Neau S. H., Chow M. Y., Durrani M. J. Fabrication and characterization of extruded and spheronized beads containing Carbopol® 974P, NF resin. Int. J. Pharm. 1996; 131: 47–55
   Web of Science ®Google Scholar
• Neau S. H., Chow M. Y., Hileman G. A., Durrani J., Gheyas F., Evans B. A. Formulation and process considerations for beads containing Carbopol® 974P, NF resin made by extrusion-spheronization. Int. J. Pharm. 2000; 199: 129–140
   PubMed Web of Science ®Google Scholar
• O'Connor R. E., Holinez J., Schwartz J. B. Spheronization I: Processing and evaluation of spheres prepared from commercially available excipients. Am. J. Pharm. 1984; 150: 80–87
   Google Scholar
• O'Connor R. E., Schwartz J. B. Spheronization II: drug release from drug-diluent mixtures. Drug Dev. Ind. Pharm. 1985; 11: 1837–1857
   Web of Science ®Google Scholar
• Pérez-Feás C., Souto C., Martínez-Pacheco R. Utilidad de mezclas celulosa microcristalina-celulosa microfina como excipientes base en extrusión-esferonización. VI Congreso de la Sociedad Española de Farmacia Industrial y Galénica, Granada, 2003; 311–314
   Google Scholar
• Pinto J. F., Buckton G., Newton J. M. The influence of four selected processing and formulation factors on the production of spheres by extrusion and spheronisation. Int. J. Pharm. 1992; 83: 187–196
   Web of Science ®Google Scholar
• Reynolds A. D. A new technique for the production of spherical particles. Mfg. Chem. Aerosol News 1970; 40: 40–43
   Google Scholar
• Robinson R. L., Hollenbeck R. G. Manufacture of spherical acetaminophen pellets: Comparison on rotary processing with multiple step extrusion and spheronization. Pharm. Tech. 1991; 80: 48–56
   Google Scholar
• Rodríguez Gómez A., Anguiano Igea S., Otero Espinar F. J., Blanco Méndez J. Effect of bioadhesives polymers on pellets obtained by extrusion-spheronization. 3rd European Congress of Pharmaceutical Sciences, Edinburg, 1996; 15–17
   Google Scholar
• Rodríguez J. A., Gómez-Amoza J. L., Souto C., Martínez-Pacheco R. Evaluación d la actividad disgregante de una carboximetilcelulosa sódica reticulada en pelets de hidroclortiazida-celulosa microcristalina. VI Congreso de la Sociedad Española de Farmacia Industrial y Galénica, Granada, 2003; 189–192
   Google Scholar
• Schmidt W. G., Mehner W., Frömming K. H. Controlled release from spherical matrices prepared in a laboratory scale rotor granulator release mechanism interpretation using individual pellets data. Eur. J. Pharm. Biopharm. 1996; 42: 348–350
   Web of Science ®Google Scholar
• Schröeder M., Kleinebudde P. Influence of formulation parameters on dissolution of propyphenazone pellets. Eur. J. Pharm. Biopharm. 1995; 41: 382–387
   Web of Science ®Google Scholar
• Sousa J. J., Sousa A., Podczeck F., Newton J. M. Influence of process conditions on drug release from pellets. Int. J. Pharm. 1996; 144: 159–169
   Web of Science ®Google Scholar
• Tapia C., Buckton G., Newton J. M. Factors influencing the mechanism of release form sustained release matrix pellets, produced by extrusion/spheronisation. Int. J. Pharm. 1993; 92: 211–218
   Web of Science ®Google Scholar
• Varshosaz J., Kennedy R. A., Gipps E. M. Effect of binder level and granulating liquid of phenylbutazone pellets prepared by extrusion-spheronization. Drug Dev. Ind. Pharm. 1997; 23: 611–618
   Web of Science ®Google Scholar
• Vila Jato J. L., Blanco Méndez J., Otero Espinar F. J., Anguiano Igea S., Amela J. Obtention of bioadhesive pellets by extrusion/spheronisation. 1st World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Budapest, 1995; 821–822
   Google Scholar
• Villar-López M. E., Nieto-Reyes L., Anguiano-Igea S., Otero-Espinar F. J., Blanco-Méndez J. Formulation of triamcinolone acetonide pellets suitable for coating and colon targeting. Int. J. Pharm. 1999; 179: 229–235
   PubMed Web of Science ®Google Scholar
• Zhang G., Schwartz J. B., Schnaare R. L. Effect of spheronization technique on drug release from uncoated beads. Drug. Dev. Ind. Pharm. 1990; 16: 1171–1184
   Web of Science ®Google Scholar
• Zhang G., Schwartz J. B., Schnaare R. L., Wigent R. J., Sugita E. T. Bead coating II: Effect of spheronization technique on drug release from coated spheres. Drug. Dev. Ind. Pharm. 1991; 17: 817–830
   Web of Science ®Google Scholar
• Zhou F., Vervaet C., Massart D. L., Massart B., Remon J. P. Optimization of the processing of matrix pellets based on the combination of waxes and starch using experimental design. Drug. Dev. Ind. Pharm. 1998; 24: 353–358
   PubMed Web of Science ®Google Scholar
• Zhou F., Vervaet C., Remon J. P. Matrix pellets based on the combinations of waxes, starches and maltodextrins. Int. J. Pharm. 1996; 133: 155–160
   Web of Science ®Google Scholar
• Zhou F., Vervaet C., Remon J. P. Influence of processing on the characteristics of matrix pellets based on microcrystalline waxes and starch derivates. Int. J. Pharm. 1997; 147: 23–30
   Web of Science ®Google Scholar
• Zhou F., Vervaet C., Schelkens M., Lefebre R., Remon J. P. Bioavailabity of ibuprofen from matrix pellets based on the combination of waxes and starch derivates. Int. J. Pharm. 1998; 168: 79–84
   Web of Science ®Google Scholar